antibody-mediated rejection


Also found in: Dictionary, Thesaurus, Legal, Financial, Acronyms, Encyclopedia.

antibody-mediated rejection

Rejection of a transplanted organ due to the action of antibodies against antigens found on the endothelial surface of blood vessels.
See also: rejection
References in periodicals archive ?
Antibody-mediated rejection in human cardiac allografts: evaluation of immunoglobulins and complement activation products C4d and C3d as markers.
2016 Comprehensive update of the Banff Working Group on Liver Allograft Pathology: introduction of antibody-mediated rejection [published online ahead of print June 7, 2016].
Correlation of donor-specific antibodies, complement and its regulators with graft dysfunction in cardiac antibody-mediated rejection.
Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients," American Journal of Transplantation, vol.
Addition of plasmapheresis decreases the incidence of acute antibody-mediated rejection in sensitized patients with strong donor-specific antibodies.
Donor-specific antibodies are associated with antibody-mediated rejection, acute cellular rejection, bronchiolitis obliterans syndrome, and cystic fibrosis after lung transplantation.
1999) and has been used precisely to remove donor specific antibodies that would cause hyperacute rejection or acute antibody-mediated rejection (Montgomery et al.
If there is a clinical concern for antibody-mediated rejection (AMR), a separate biopsy sample may be fixed in Zeus transport medium and analyzed by immunofluorescence.
Historically, the prognosis of antibody-mediated rejection following renal transplantation is poor.
Complement activation is regarded as a key event in antibody-mediated rejection (AMR) of cardiac allografts.
Circulating donor-specific antibodies (DSA) can result in antibody-mediated rejection, which is usually associated with complement fixation and poor prognosis.
Full browser ?